Literature DB >> 8268718

Diverse molecular mechanisms of inhibition of NF-kappa B/DNA binding complexes by I kappa B proteins.

T Léveillard1, I M Verma.   

Abstract

The activity of the rel/NF-kappa B/dorsal family of kappa B site binding proteins is regulated by I kappa B proteins. The ankyrin repeat motif identified I kappa B family members, which include I kappa B alpha (pp40/MAD-3), I kappa B gamma, and bcl3, directly associated with kappa B site binding proteins, resulting in specific DNA-binding inhibition of rel, p50, or p65 dimers. We report that I kappa B gamma, containing eight ankyrin repeats, mediates a reversible inhibition of (p50)2-DNA complex but cannot displace preformed DNA-protein complexes. I kappa B alpha and bcl3, on the other hand, can displace preformed DNA-protein complexes. I kappa B alpha specifically displaces (p65)2 or p50/p65-DNA complexes but requires the C-terminal 37 amino acids in addition to the ankyrin repeat domain. Human bcl3 protein specifically displaces (p50)2-DNA complexes. Because I kappa B alpha and bcl3 can displace preformed (p65)2 or (p50)2-DNA complexes, respectively, we propose that they can act as repressors or antirepressors of NF-kappa B-induced gene expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8268718      PMCID: PMC6081632     

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  59 in total

1.  Characterization of the Drosophila cactus locus and analysis of interactions between cactus and dorsal proteins.

Authors:  S Kidd
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

2.  Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal.

Authors:  S Ghosh; A M Gifford; L R Riviere; P Tempst; G P Nolan; D Baltimore
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

Review 3.  NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.

Authors:  M J Lenardo; D Baltimore
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

4.  Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

5.  Sequence-specific antirepression of histone H1-mediated inhibition of basal RNA polymerase II transcription.

Authors:  G E Croston; L A Kerrigan; L M Lira; D R Marshak; J T Kadonaga
Journal:  Science       Date:  1991-02-08       Impact factor: 47.728

6.  Purified I kappa B-beta is inactivated upon dephosphorylation.

Authors:  E Link; L D Kerr; R Schreck; U Zabel; I Verma; P A Baeuerle
Journal:  J Biol Chem       Date:  1992-01-05       Impact factor: 5.157

7.  Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro.

Authors:  M Kretzschmar; M Meisterernst; C Scheidereit; G Li; R G Roeder
Journal:  Genes Dev       Date:  1992-05       Impact factor: 11.361

8.  The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.

Authors:  E N Hatada; A Nieters; F G Wulczyn; M Naumann; R Meyer; G Nucifora; T W McKeithan; C Scheidereit
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

9.  The precursor of NF-kappa B p50 has I kappa B-like functions.

Authors:  N R Rice; M L MacKichan; A Israël
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

10.  The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50.

Authors:  H C Liou; G P Nolan; S Ghosh; T Fujita; D Baltimore
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

View more
  10 in total

1.  Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo.

Authors:  J H Caamaño; P Perez; S A Lira; R Bravo
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

2.  The N-terminal domain of IkappaB alpha masks the nuclear localization signal(s) of p50 and c-Rel homodimers.

Authors:  M Latimer; M K Ernst; L L Dunn; M Drutskaya; N R Rice
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

3.  Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required.

Authors:  D J Van Antwerp; I M Verma
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

4.  Qualitative changes in the subunit composition of kappa B-binding complexes during murine B-cell differentiation.

Authors:  S Miyamoto; M J Schmitt; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

5.  The PEST-like sequence of I kappa B alpha is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers.

Authors:  M K Ernst; L L Dunn; N R Rice
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

6.  Autoregulation of I kappa B alpha activity.

Authors:  P J Chiao; S Miyamoto; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

7.  Histone Lys demethylase KDM3C demonstrates anti-inflammatory effects by suppressing NF-κB signaling and osteoclastogenesis.

Authors:  Jae Young Lee; Shebli Mehrazarin; Abdullah Alshaikh; Sol Kim; Wei Chen; Renate Lux; Yousang Gwack; Reuben H Kim; Mo K Kang
Journal:  FASEB J       Date:  2019-06-28       Impact factor: 5.191

Review 8.  Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages.

Authors:  Amin Majdalawieh; Hyo-Sung Ro
Journal:  Mediators Inflamm       Date:  2010-04-12       Impact factor: 4.711

9.  Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines.

Authors:  S Miyamoto; P J Chiao; I M Verma
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

10.  Prevention of Streptozotocin-Induced Diabetic Nephropathy by MG132: Possible Roles of Nrf2 and IκB.

Authors:  Lili Kong; Yangwei Wang; Manyu Luo; Yi Tan; Wenpeng Cui; Lining Miao
Journal:  Oxid Med Cell Longev       Date:  2017-03-08       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.